Comparison of transesophageal echocardiographic analysis and circulating biomarker expression profile in calcific aortic valve disease

Rachana Sainger, Juan B. Grau, Emanuela Branchetti, Paolo Poggio, Eric Lai, Erblina Koka, William J. Vernick, Robert C. Gorman, Joseph E. Bavaria, Giovanni Ferrari

Research output: Contribution to journalArticle

Abstract

Background and aim of the study: Aortic valve sclerosis (AVSc), the early asymptomatic stage of calcific aortic valve disease (CAVD), is characterized by a progressive thickening of the aortic cusps without obstruction of the left ventricular outflow. In spite of its high prevalence, there are no molecular markers to characterize the early stages of CAVD before it progresses to a severe, symptomatic stage of aortic valve stenosis (AVS). The study aim was to identify any correlation between circulating biomarkers and transesophageal echocardiography (TEE) evaluation. Methods: A total of 330 patients with various degrees of CAVD was enrolled into the study. Blood was collected from each patient prior to surgery, and analyzed using ELISA kits following the manufacturers' instructions. Results: Significantly higher plasma osteopontin (OPN) levels were observed in AVSc patients (72.7 ± 1.8 ng/ml; p

Original languageEnglish
Pages (from-to)156-165
Number of pages10
JournalJournal of Heart Valve Disease
Volume22
Issue number2
Publication statusPublished - Mar 2013

Fingerprint

Aortic Diseases
Aortic Valve
Biomarkers
Sclerosis
Ventricular Outflow Obstruction
Osteopontin
Transesophageal Echocardiography
Aortic Valve Stenosis
Enzyme-Linked Immunosorbent Assay

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Comparison of transesophageal echocardiographic analysis and circulating biomarker expression profile in calcific aortic valve disease. / Sainger, Rachana; Grau, Juan B.; Branchetti, Emanuela; Poggio, Paolo; Lai, Eric; Koka, Erblina; Vernick, William J.; Gorman, Robert C.; Bavaria, Joseph E.; Ferrari, Giovanni.

In: Journal of Heart Valve Disease, Vol. 22, No. 2, 03.2013, p. 156-165.

Research output: Contribution to journalArticle

Sainger, R, Grau, JB, Branchetti, E, Poggio, P, Lai, E, Koka, E, Vernick, WJ, Gorman, RC, Bavaria, JE & Ferrari, G 2013, 'Comparison of transesophageal echocardiographic analysis and circulating biomarker expression profile in calcific aortic valve disease', Journal of Heart Valve Disease, vol. 22, no. 2, pp. 156-165.
Sainger, Rachana ; Grau, Juan B. ; Branchetti, Emanuela ; Poggio, Paolo ; Lai, Eric ; Koka, Erblina ; Vernick, William J. ; Gorman, Robert C. ; Bavaria, Joseph E. ; Ferrari, Giovanni. / Comparison of transesophageal echocardiographic analysis and circulating biomarker expression profile in calcific aortic valve disease. In: Journal of Heart Valve Disease. 2013 ; Vol. 22, No. 2. pp. 156-165.
@article{268a2cabc79d490aabc9fbdebae06e2e,
title = "Comparison of transesophageal echocardiographic analysis and circulating biomarker expression profile in calcific aortic valve disease",
abstract = "Background and aim of the study: Aortic valve sclerosis (AVSc), the early asymptomatic stage of calcific aortic valve disease (CAVD), is characterized by a progressive thickening of the aortic cusps without obstruction of the left ventricular outflow. In spite of its high prevalence, there are no molecular markers to characterize the early stages of CAVD before it progresses to a severe, symptomatic stage of aortic valve stenosis (AVS). The study aim was to identify any correlation between circulating biomarkers and transesophageal echocardiography (TEE) evaluation. Methods: A total of 330 patients with various degrees of CAVD was enrolled into the study. Blood was collected from each patient prior to surgery, and analyzed using ELISA kits following the manufacturers' instructions. Results: Significantly higher plasma osteopontin (OPN) levels were observed in AVSc patients (72.7 ± 1.8 ng/ml; p",
author = "Rachana Sainger and Grau, {Juan B.} and Emanuela Branchetti and Paolo Poggio and Eric Lai and Erblina Koka and Vernick, {William J.} and Gorman, {Robert C.} and Bavaria, {Joseph E.} and Giovanni Ferrari",
year = "2013",
month = "3",
language = "English",
volume = "22",
pages = "156--165",
journal = "Journal of Heart Valve Disease",
issn = "0966-8519",
publisher = "ICR Publishers Ltd",
number = "2",

}

TY - JOUR

T1 - Comparison of transesophageal echocardiographic analysis and circulating biomarker expression profile in calcific aortic valve disease

AU - Sainger, Rachana

AU - Grau, Juan B.

AU - Branchetti, Emanuela

AU - Poggio, Paolo

AU - Lai, Eric

AU - Koka, Erblina

AU - Vernick, William J.

AU - Gorman, Robert C.

AU - Bavaria, Joseph E.

AU - Ferrari, Giovanni

PY - 2013/3

Y1 - 2013/3

N2 - Background and aim of the study: Aortic valve sclerosis (AVSc), the early asymptomatic stage of calcific aortic valve disease (CAVD), is characterized by a progressive thickening of the aortic cusps without obstruction of the left ventricular outflow. In spite of its high prevalence, there are no molecular markers to characterize the early stages of CAVD before it progresses to a severe, symptomatic stage of aortic valve stenosis (AVS). The study aim was to identify any correlation between circulating biomarkers and transesophageal echocardiography (TEE) evaluation. Methods: A total of 330 patients with various degrees of CAVD was enrolled into the study. Blood was collected from each patient prior to surgery, and analyzed using ELISA kits following the manufacturers' instructions. Results: Significantly higher plasma osteopontin (OPN) levels were observed in AVSc patients (72.7 ± 1.8 ng/ml; p

AB - Background and aim of the study: Aortic valve sclerosis (AVSc), the early asymptomatic stage of calcific aortic valve disease (CAVD), is characterized by a progressive thickening of the aortic cusps without obstruction of the left ventricular outflow. In spite of its high prevalence, there are no molecular markers to characterize the early stages of CAVD before it progresses to a severe, symptomatic stage of aortic valve stenosis (AVS). The study aim was to identify any correlation between circulating biomarkers and transesophageal echocardiography (TEE) evaluation. Methods: A total of 330 patients with various degrees of CAVD was enrolled into the study. Blood was collected from each patient prior to surgery, and analyzed using ELISA kits following the manufacturers' instructions. Results: Significantly higher plasma osteopontin (OPN) levels were observed in AVSc patients (72.7 ± 1.8 ng/ml; p

UR - http://www.scopus.com/inward/record.url?scp=84880578364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880578364&partnerID=8YFLogxK

M3 - Article

C2 - 23798203

AN - SCOPUS:84880578364

VL - 22

SP - 156

EP - 165

JO - Journal of Heart Valve Disease

JF - Journal of Heart Valve Disease

SN - 0966-8519

IS - 2

ER -